Get started
Author

G. Gorospe

Observed names: Gerardo Gorospe, Gerardo L. Gorospe
ORCID: 0000-0001-9237-5536
Observed ORCID: 0000-0001-9237-5536
OpenAlex ID: A5063276594
Phase I Study of Antisense Oligonucleotide Against Vascular Endothelial Growth Factor: Decrease in Plasma Vascular Endothelial Growth Factor With Potential Clinical Efficacy
2006 · Alexandra M. Levine, Anil Tulpule, et al. · Journal of Clinical Oncology · 62
PDF
Developing and Monitoring a Standard-of-Care Chimeric Antigen Receptor (CAR) T Cell Clinical Quality and Regulatory Program
2020 · Sylvia O. Dulan, Kathie L. Viers, et al. · Transplantation and Cellular Therapy · 12
Phase I trial of anti-sense oligonucleotide vascular endothelial growth factor (VEGF-AS, Veglin) in patients with relapsed and refractory malignancies
2004 · A. M. Levine, D. I. Quinn, et al. · Journal of Clinical Oncology · 8
A phase II trial of pegylated liposomal doxorubicin, rituximab, cyclophosphamide, vincristine, and prednisone (DR-COP) in aggressive B-cell non-Hodgkin’s lymphoma
2005 · A. Tulpule, C. A. Duran, et al. · Journal of Clinical Oncology · 3
A phase II trial of pegylated liposomal doxorubicin, rituximab, cyclophosphamide, vincristine, and prednisone (DR-COP) in aggressive B-cell non-Hodgkin's lymphoma
2004 · A. Tulpule, A. U. Khan, et al. · Journal of Clinical Oncology · 2
The advance directive completion rates in the hematopoietic stem cell transplant population in a major transplant cancer center.
2017 · Finly Zachariah, Leslie Popplewell, et al. · Journal of Clinical Oncology · 1
Creating a Phototherapy Service for Skin GVHD and Other Skin Disorders: Role and Competency of Phototherapy Nurse
2017 · Gerardo Gorospe, Mary Perrin, et al. · Transplantation and Cellular Therapy · 1
Managing of Daily Improvement (MDI) Through Daily Huddles: Creating Culture and Engaged Problem Solving Nurse Coordinator Staff at City of Hope Department of Hematology & Hematopoietic Cell Transplant (HEM/HCT)
2013 · Gerardo Gorospe, Shirley Johnson, et al. · Transplantation and Cellular Therapy · 1
157 Phase I trial of an antisense to vascular endothelial growth factor (VEGF-AS, Veglin) in relapsed and refractory malignancies
2004 · D.I. Quinn, A.M. Levine, et al. · European Journal of Cancer Supplements · 1
Feasibility and predictive utility of implementing a modified practical geriatric assessment for older adults with gastrointestinal cancer
2025 · K. Chang, T.L. Thein, et al. · Journal of Geriatric Oncology
Using Virtual Interdisciplinary Geriatric Oncology Review (VIGOR) Rounds to Identify Interventions for High-risk Older Adults with Cancer
2025 · Kevin Chang, Tiffany Thein, et al. · International Journal of Cancer Care and Delivery
Pre-Transplant Caregiver Education for Out-Patient Multiple Myeloma Hematopoietic Transplant Admission in New Day Hospital: Caregiver Role and Contract in Outpatient Transplant Patient Care
2015 · Gerardo Gorospe, Liz Cooke, et al. · Transplantation and Cellular Therapy
Establishing a Shared Governance, Unit Based Council for the Hematology/Hematopoietic Cell Transplantation (Hem/HCT) Nurse Coordinator (NC) and Clinical Trial Nurse (CTN)
2013 · Donna Hawkins, Kathryn Irenze, et al. · Transplantation and Cellular Therapy
PDF
A “Road Map” to Create a Standardized, Defect Free Hematopoietic Cell Transplant (HCT) Schedule Utilizing Lean Methodology – A3 Thinking
2012 · J. Reyes, J. Seerup, et al. · Transplantation and Cellular Therapy
P139 A phase I biological study of azacitidine (Vidaza) to determine the optimal biological dose and route of administration
2009 · A.S. Yang, A. Mohrbacher, et al. · Leukemia Research
A phase II trial of pegylated liposomal doxorubicin, rituximab, cyclophosphamide, vincristine, and prednisone (DR-COP) in aggressive B-cell non-Hodgkin's lymphoma
2004 · A. Tulpule, A. U. Khan, et al. · Journal of Clinical Oncology
Works count: 16
Citation count: 91
H-index: 3
I10-index: 2
Year
Topic
Type